The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
The Role of Prolactin in Mammary Carcinoma
Open accessAbstract
The contribution of prolactin (PRL) to the pathogenesis and progression of human breast cancer at the cellular, transgenic, and epidemiological levels is increasingly appreciated. Acting at the endocrine and autocrine/paracrine levels, PRL functions to stimulate the growth and motility of human breast cancer cells. The actions of this ligand are mediated by at least six recognized PRL receptor isoforms found on, or secreted by, human breast epithelium. The PRL/PRL receptor complex associates with and activates several signaling networks that are shared with other members of the cytokine receptor superfamily. Coupled with the recently identified intranuclear function of PRL, these networks are integrated into the in vitro and in vivo actions induced by ligand. These findings indicate that antagonists of PRL/PRL receptor interaction or PRL receptor-associated signal transduction may be of considerable utility in the treatment of human breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–251 of 251
Clinical management of prolactinomas
Webster, J. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0030 · Cited by 62
SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
Tomić, S., Chughtai, N., & Ali, S. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00180-x · Cited by 61
Berchtold, S., Volarević, S., Moriggl, R., Merćep, M., & Groner, B. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.4.0086 · Cited by 60
Canbay, E., Norman, M., Kılıç, E., Goffin, V., & Zachary, I. C. (1997) · Biochemical Journal · doi:10.1042/bj3240231 · Cited by 59
Immune signalling: SHP-2 docks at multiple ports
Huyer, G., & Alexander, D. R. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80080-3 · Cited by 54
Postmarketing surveillance of the safety of cimetidine: 10 year mortality report.
Colin-Jones, D. G., Langman, M. J. S., Lawson, D. H., Logan, R., Paterson, K. R., & Vessey, M. P. (1992) · Gut · doi:10.1136/gut.33.9.1280 · Cited by 54
Fielding, C. J. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00007 · Cited by 54
Plasma prolactin levels in patients with breast cancer
Rose, D. P., & Pruitt, B. T. (1981) · Cancer · Cited by 53
Thürigen, D., Spiegelman, D. L., Blettner, M., Heuer, C., & Brenner, H. (2000) · Statistical Methods in Medical Research · doi:10.1177/096228020000900504 · Cited by 51
Al‐Sakkaf, K., Dobson, P. R. M., & BROWN, B. L. (1997) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0190347 · Cited by 51
Endogenous Sex Hormones, Prolactin, and Breast Cancer in Premenopausal Women2
Meyer, F., Brown, J. B., Morrison, A. S., & MacMahon, B. (1986) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/77.3.613 · Cited by 51
Plasma hormones in pre- and postmenopausal breast cancer
Drafta, D., Schindler, A. E., Milcu, S. M., Keller, E., Stroe, E., Horodniceanu, E., & Bălănescu, I. (1980) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(80)90231-9 · Cited by 49
Aromaa, A., Hakama, M., Hakulinen, T. R., Saxén, E., Teppo, L., & Idänpään-Heikkilä, J. J. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910180603 · Cited by 49
Identification of Cytoplasmic Motifs Required for Short Prolactin Receptor Internalization
Vincent, V., Goffin, V., Rozakis-Adcock, M., Mornon, J., & Kelly, P. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7062 · Cited by 49
RAUWOLFIA DERIVATIVES AND BREAST CANCER IN HYPERTENSIVE WOMEN
Armstrong, B. K., White, G., Skegg, D. C. G., et al. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92966-4 · Cited by 49
Prolactin-induced Cell Proliferation in PC12 Cells Depends on JNK but Not ERK Activation
Cheng, Y., Zhizhin, I., Perlman, R. L., & Mangoura, D. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001837200 · Cited by 48
Growth factors in breast cancer: Mitogenesis to transformation
Dickson, R. B., JOHNSON, M., Bano, M., Shi, E., Kurebayashi, J., Ziff, B. L., Martínez-Lacaci, I., Amundadottir, L. T., & Lippman, M. E. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90189-p · Cited by 48
Bonneterre, J. M., Mauriac, L., Weber, B. E., Roche, H. H., Fargeot, P., Tubiana-Hulin, M., Sevin, M., Chollet, P. J. M., & Cappelaere, P. (1988) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(88)90097-1 · Cited by 48
Beck, M. T., Peirce, S. K., & Chen, W. Y. (2002) · Oncogene · doi:10.1038/sj.onc.1205637 · Cited by 48
Prolactin Mediated Intracellular Signaling in Mammary Epithelial Cells
Hynes, N. E., Cella, N., & Wartmann, M. (1997) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1026317428542 · Cited by 47
Rao, Y.-P., Buckley, D. J., Olson, M. D., & Buckley, A. R. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041630207 · Cited by 47
PROGRAM, B. C. D. S. (1974) · The Lancet · doi:10.1016/s0140-6736(74)93257-7 · Cited by 47
Bioactive and immunoreactive prolactin variants in human milk
Ellis, L. A., & Picciano, M. F. (1995) · Endocrinology · doi:10.1210/endo.136.6.7750496 · Cited by 46
Pituitary adenoma and bilateral male breast cancer: An unusual association
Volm, M. D., Talamonti, M. S., Thangavelu, M., & Gradishar, W. J. (1997) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199701)64:1<74::aid-jso14>3.0.co;2-w · Cited by 45
Kwa, H. G., & Wang, D. Y. (1977) · International Journal of Cancer · doi:10.1002/ijc.2910200104 · Cited by 43
Plasma hormone profiles of young women at risk for familial breast cancer.
Fishman, J., Fukushima, D. K., O’Connor, J. F., et al. (1978) · PubMed · Cited by 40
Gao, J., Hughes, J. P., Aupérin, B., Buteau, H., Edery, M., Zhuang, H., Wojchowski, D., & Horseman, N. D. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.7.8813725 · Cited by 40
Ali, S., & Ali, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007478200 · Cited by 39
Kinet, S., Bernichtein, S., Kelly, P. A., MARTIAL, J. A., & Goffin, V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26033 · Cited by 39
Endocrine status in normal British, Japanese and Hawaiian-Japanese women
Hayward, J. L., Greenwood, F. C., Glober, G. A., Stemmerman, G. N., Bulbrook, R. D., Wang, D. Y., & Kumaokas, S. (1978) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(78)90228-1 · Cited by 39
Kjær, A., Knigge, U., Olsen, L. O., Vilhardt, H., & Warberg, J. (1991) · Endocrinology · doi:10.1210/endo-128-1-103 · Cited by 38
Kazansky, A. V., & Rosen, J. M. (2001) · PubMed · Cited by 38
Estrogens in tissues: Uptake from the peripheral circulation or local production
Thijssen, J. H. H., Blankenstein, M. A., Miller, W. R., & Milewicz, A. (1987) · Steroids · doi:10.1016/0039-128x(83)90079-x · Cited by 36
Prolactin Stimulates Activation of c-jun N-Terminal Kinase (JNK)
Schwertfeger, K. L., Hunter, S., Heasley, L. E., Levresse, V., Leon, R. P., DeGregori, J. V., & Anderson, S. M. (2000) · Molecular Endocrinology · doi:10.1210/me.14.10.1592 · Cited by 36
Labarthe, D. R. (1980) · JAMA · doi:10.1001/jama.1980.03300480024019 · Cited by 34
Genty, N., Paly, J., Edery, M., Kelly, P. A., Djiane, J., & Salesse, R. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90011-6 · Cited by 34
Cole, E. N., England, P., Sellwood, R. A., & Griffiths, K. (1977) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(77)90053-6 · Cited by 34
Lactogenic Hormone Signal Transduction1
Yu-Lee, L.-Y., Luo, G., Book, M. L., & Morris, S. M. (1998) · Biology of Reproduction · doi:10.1095/biolreprod58.2.295 · Cited by 34
Serum prolactin levels and their relationship to survival in women with operable breast cancer
Wang, D. Y., Stepniewska, K., Allen, D. S., Fentiman, I., Bulbrook, R. D., Kwa, H. G., Stavola, B. L. D., & Reed, M. J. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00201-z · Cited by 32
Crighton, I. L., Dowsett, M., Hunter, M., Shaw, C., & Smith, I. E. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90252-w · Cited by 31
Inhibition of Tumor Growth by the Antiangiogenic Placental Hormone, Proliferin-Related Protein
Bengtson, N. W., & Linzer, D. I. H. (2000) · Molecular Endocrinology · doi:10.1210/me.14.12.1934 · Cited by 29
Lu, J.-C., Scott, P. A., Strous, G. J., & Schuler, L. A. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0077 · Cited by 28
Self-citationShultz, T. D., Wilcox, R. B., Spuehler, J. M., & Howie, B. J. (1987) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/46.6.905 · Cited by 26
Comparison of Urinary and Plasma Hormone Levels in Daughters of Breast Cancer Patients and Controls2
Pike, M. C., Casagrande, J. T., Brown, J. B., Gerkins, V. R., & Henderson, B. E. (1977) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/59.5.1351 · Cited by 25
Multiple mutations of the p53 gene in human mammary carcinoma
Meng, L., Lin, L., Zhang, H., Nassiri, M., Morales, A. R., & Nadji, M. (1999) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(99)00053-1 · Cited by 22
Conditional Control of Gene Expression in the Mammary Gland
Furth, P. A. (1997) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1026399329934 · Cited by 19
Self-citationCultured Nb rat lymphoma cells in endocrine and cancer research
Gout, P. W., NOBLE, R. L., & Beer, C. T. (1986) · Biochemistry and Cell Biology · doi:10.1139/o86-091 · Cited by 18
Gao, J., & Horseman, N. D. (1999) · Cellular Signalling · doi:10.1016/s0898-6568(98)00067-9 · Cited by 16
Prolactin in Human Breast Cancer Development
Vonderhaar, B. K. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-223-4_7 · Cited by 15
Hypothalamic Control of Prolactin Synthesis and Secretion
Ben‐Jonathan, N. (2001) · Endocrine updates · doi:10.1007/978-1-4615-1683-5_1 · Cited by 12
Involvement of c-src in β-Casein Expression by Mammary Epithelial Cells
Sørensen, P., & Sheffield, L. G. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7879 · Cited by 10
Cited by
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981
Advances in the Treatment of Prolactinomas
Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A. (2006) · Endocrine Reviews · doi:10.1210/er.2005-9998 · Cited by 824
The Nurses׳ Health Study: lifestyle and health among women
Colditz, G. A., & Hankinson, S. E. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1608 · Cited by 590
Self-citationFatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
Qu, Q., Zeng, F., Liu, X., Wang, Q. J., & Deng, F. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.132 · Cited by 545
What Can We Learn from Rodents about Prolactin in Humans?
Ben-Jonathan, N., LaPensee, C. R., & LaPensee, E. W. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0017 · Cited by 523
Metadata
- Authors
- Clevenger, C. V., Furth, P. A., Hankinson, S. E., & Schuler, L. A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-02-01
- Volume
- 24
- Issue
- 1
- Pages
- 1-27
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2023523424
- Cited by
- 545
- References
- 251
- FWCI
- 20.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.